Waldenström Macroglobulinemia
📧 Sign up to get email alerts when something new happens for Waldenström Macroglobulinemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Study of BTK Inhibitor BGB-3111 in Chinese Subjects With Relapsed/Refractory Waldenström's Macroglobulinemia (WM) [Phase 2]
Phase 2 study of the BTK inhibitor BGB-3111 (zanubrutinib) in Chinese patients with relapsed/refractory Waldenström's macroglobulinemia has …
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing [Phase 2]
Phase 2 trial evaluating ibrutinib in symptomatic, previously untreated Waldenstrom's macroglobulinemia with analysis of tumor genomic evolu…
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating BI-1206 in combination with an anti-CD20 antibody for CD32b-positive B-cell lymphoma or leukemia; study …
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia [Phase 2]
Phase 2 trial of ABT-199 (GDC-199) in relapsed/refractory Waldenström macroglobulinemia completed.
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating bortezomib, rituximab, dexamethasone with or without temsirolimus in untreated or relapsed Waldenström macroglobu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 trial evaluating bortezomib, dexamethasone, and rituximab in previously untreated Waldenström's macroglobulinemia has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating everolimus, bortezomib, and/or rituximab in relapsed/refractory Waldenström's macroglobulinemia; study terminated…
-
CLINICAL_TRIALS trial_result · 2021-04-22Clinical Trial Update: A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia [Phase 2]
Phase 2 trial of daratumumab in relapsed or refractory Waldenström macroglobulinemia has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL) [Phase 1]
Phase 1 trial in Japanese participants assessing safety, tolerability, and pharmacokinetics of idelalisib in relapsed or refractory indolent…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 clinical trial update for LBH589 in Waldenström's macroglobulinemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Fase II Study With BRB for Non-Hodgkin Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia's [Phase 2]
A Phase 2 clinical trial update for BRB in Waldenström's macroglobulinemia (non-Hodgkin lymphoplasmacytic lymphoma) has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia [Phase 3]
Phase 3 trial of ibrutinib with rituximab in adults with Waldenström's macroglobulinemia has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma [Phase 2]
Phase 2 trial assessing treatment in patients with Waldenstrom's Macroglobulinemia or Multiple Myeloma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 trial investigating ixazomib with dexamethasone and rituximab in untreated Waldenström's macroglobulinemia has completed with result…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 clinical trial updating Rituximab use in Waldenström's macroglobulinemia.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 safety and tolerability study of PCI-32765 in various B-cell malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia [Phase 2]
This is a Phase 2 open-label study evaluating ACP-196 (acalabrutinib) in patients with Waldenström macroglobulinemia. The study results were…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) [Phase 1]
Phase 1 study of ADCT-402 in relapsed or refractory B-cell lineage non-Hodgkin lymphoma completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating everolimus and lenalidomide in relapsed or refractory non-Hodgkin or Hodgkin lymphoma; results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia [Phase 2]
Phase 2 trial of ibrutinib (PCI-32765) in Waldenström's macroglobulinemia completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma [Phase 2]
Phase 2 trial evaluating carfilzomib with or without rituximab in Waldenström macroglobulinemia or marginal zone lymphoma; study terminated …
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]
Phase 1/2 dose-escalation study in relapsed or refractory Waldenström's macroglobulinemia, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Study of MLN8237 in Participants With Advanced Hematological Malignancies [Phase 1]
Phase 1 study of MLN8237 in advanced hematological malignancies completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial evaluating autologous peripheral blood stem cell transplant followed by donor bone marrow transplant in high-risk B- …
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients [Phase 2]
A Phase 2 trial evaluating repeated dosing of a high-dose influenza vaccine in patients with gammopathy (including multiple myeloma and rela…